Daan Thuijs

Daan Thuijs is a Researcher at Erasmus MC in the Department of Cardiothoracic Surgery, affiliated with Erasmus University Rotterdam. His work focuses on cardiovascular interventions, particularly comparing surgical and percutaneous revascularization techniques, and their long-term survival outcomes. Key research areas include SYNTAX trial extensions, biomarker analysis (e.g., γ-glutamyl transferase), and patient-reported health impacts on mortality.

• University: Erasmus University Rotterdam
• Affiliation: Erasmus MC (Medical Center)
• Department: Cardiothoracic Surgery

His research emphasizes translational cardiology, with a focus on optimizing revascularization strategies and understanding prognostic factors in coronary artery disease. Recent studies analyze 10-year survival benefits, left ventricular ejection fraction effects, and repeat intervention outcomes in SYNTAX trial populations.

Publications highlight methodological rigor in large-scale clinical trials, with contributions to peer-reviewed journals like European Journal of Cardio-thoracic Surgery and Circulation. Collaborations span international teams, including investigators from the SYNTAX Extended Survival (SYNTAXES) study.